Glecaprevir
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13879 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 36 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | HIV infectious disease | KG + DL |
| 2 | hepatitis B virus infection | KG + DL |
| 3 | simian immunodeficiency virus infection | KG + DL |
| 4 | feline acquired immunodeficiency syndrome | KG + DL |
| 5 | hepatitis E virus infection | KG + DL |
| 6 | hepatitis, viral, animal | KG + DL |
| 7 | hepatitis A virus infection | KG + DL |
| 8 | Omsk hemorrhagic fever | KG + DL |
| 9 | Kyasanur forest disease | KG + DL |
| 10 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 11 | chronic hepatitis B virus infection | KG + DL |
| 12 | obsolete familial combined hyperlipidemia | KG + DL |
| 13 | fibroma of prostate | KG + DL |
| 14 | benign reproductive system neoplasm | KG + DL |
| 15 | Brenner tumor | KG + DL |
| 16 | benign prostate phyllodes tumor | KG + DL |
| 17 | male reproductive organ cancer | KG + DL |
| 18 | prostate leiomyoma | KG + DL |
| 19 | prostate cancer/brain cancer susceptibility | KG + DL |
| 20 | homozygous familial hypercholesterolemia | KG + DL |
| 21 | commissural lip fistula | KG + DL |
| 22 | osteoradionecrosis of the mandible | KG + DL |
| 23 | oral leukoedema | KG + DL |
| 24 | burning mouth syndrome | KG + DL |
| 25 | oral candidiasis | KG + DL |
| 26 | hypercholesterolemia, autosomal dominant | KG + DL |
| 27 | AIDS | KG + DL |
| 28 | hereditary thrombocytopenia with normal platelets | KG + DL |
| 29 | marcothrombocytopenia with mitral valve insufficiency | KG + DL |
| 30 | transient neonatal thrombocytopenia | KG + DL |
| 31 | idiopathic copper-associated cirrhosis | KG + DL |
| 32 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 33 | hepatoportal sclerosis | KG + DL |
| 34 | primitive portal vein thrombosis | KG + DL |
| 35 | hepatopulmonary syndrome | KG + DL |
| 36 | dense granule disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.